AMBBY (Ambu AS) Cyclically Adjusted Revenue per Share: $2.60 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMBBY Ambu AS AMBBY
84 GF Score
Price $9.70
GF Value $19.35
Valuation Significantly Undervalued
View Full Analysis

What is Ambu AS Cyclically Adjusted Revenue per Share?

Ambu AS AMBBY 84 Cyclically Adjusted Revenue per Share is $2.60 as of Mar. 2026. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.35 (Significantly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ambu AS's adjusted revenue per share for the three months ended in Mar. 2026 was $0.925. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $2.60 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Ambu AS's average Cyclically Adjusted Revenue Growth Rate was 9.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Ambu AS was 17.60% per year. The lowest was 10.80% per year. And the median was 14.20% per year.

As of today (2026-07-14), Ambu AS's current stock price is $9.70. Ambu AS's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $2.60. Ambu AS's Cyclically Adjusted PS Ratio of today is 3.73.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ambu AS was 41.52. The lowest was 3.53. And the median was 12.93.


Ambu AS  (OTCPK:AMBBY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ambu AS's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.70/2.60
=3.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ambu AS was 41.52. The lowest was 3.53. And the median was 12.93.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ambu AS Cyclically Adjusted Revenue per Share Related Terms


Ambu AS Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Ambu AS's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambu AS Cyclically Adjusted Revenue per Share Chart

Ambu AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 1.54 1.92 2.22 2.61

Ambu AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.28 2.52 2.61 2.53 2.60

AMBBY vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Ambu AS's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambu AS Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ambu AS's Cyclically Adjusted PS Ratio falls into.


AMBBY
84GF Score
Ambu AS AMBBY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambu AS Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ambu AS's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.925/121.6800*121.6800
=0.925

Current CPI (Mar. 2026) = 121.6800.

Ambu AS Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.319 100.600 0.386
201609 0.360 100.200 0.437
201612 0.309 100.300 0.375
201703 0.367 101.200 0.441
201706 0.376 101.200 0.452
201709 0.416 101.800 0.497
201712 0.345 101.300 0.414
201803 0.426 101.700 0.510
201806 0.424 102.300 0.504
201809 0.470 102.400 0.558
201812 0.397 102.100 0.473
201903 0.475 102.900 0.562
201906 0.471 102.900 0.557
201909 0.363 102.900 0.429
201912 0.458 102.900 0.542
202003 0.590 103.300 0.695
202006 0.575 103.200 0.678
202009 0.551 103.500 0.648
202012 0.655 103.400 0.771
202103 0.641 104.300 0.748
202106 0.610 105.000 0.707
202109 0.640 105.800 0.736
202112 0.627 106.600 0.716
202203 0.655 109.900 0.725
202206 0.629 113.600 0.674
202209 0.601 116.400 0.628
202212 0.659 115.900 0.692
202303 0.684 117.300 0.710
202306 0.648 116.400 0.677
202309 0.676 117.400 0.701
202312 0.698 116.700 0.728
202403 0.747 118.400 0.768
202406 0.744 118.500 0.764
202409 0.780 118.900 0.798
202412 0.788 118.900 0.806
202503 0.851 120.200 0.861
202506 0.871 120.700 0.878
202509 0.862 121.600 0.863
202512 0.911 121.200 0.915
202603 0.925 121.680 0.925

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $2.60 mean?
Ambu AS (AMBBY) has a Cyclically Adjusted Revenue per Share of $2.60 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ambu AS and its competitors.
Is Ambu AS's Cyclically Adjusted Revenue per Share too high?
Ambu AS's current Cyclically Adjusted Revenue per Share is $2.60. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Ambu AS's Cyclically Adjusted Revenue per Share of $2.60 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Ambu AS and its competitors. Ambu AS's current Cyclically Adjusted Revenue per Share is $2.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.35, compared to a current price of $9.70 — trading 49.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $2.60. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Cyclically Adjusted Revenue per Share is $2.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambu AS (AMBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued. The current stock price of $9.70 is trading 49.9% below its estimated GF Value™ of $19.35. GuruFocus considers Ambu AS to be Significantly Undervalued.

Key valuation signals for AMBBY:

  • Cyclically Adjusted Revenue per Share: $2.60
  • GF Value™: $19.35 vs. price of $9.70 (49.9% below fair value)
  • GF Score™: 84/100

No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ambu AS Business Description

Address Baltorpbakken 13, Ballerup, DNK, DK-2750
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score

Get the complete analysis for AMBBY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.70
Price
$19.35
GF Value